ATLAS / Macro Radar / Reporting / LGND

LIGAND PHARMACEUTICALS INC (LGND) reporting calendar

LIGAND PHARMACEUTICALS INC files periodic reports with the SEC as LGND on Nasdaq. Atlas tracks 46 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
29 Jul 2026 – 18 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
8 May 2026
Reports on record
46

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 39 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open LGND market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20268 May 202638 days0000886163-26-000034
10-K31 Dec 202527 Feb 202658 days0000886163-26-000006
10-Q30 Sep 20257 Nov 202538 days0000886163-25-000063
10-Q30 Jun 20258 Aug 202539 days0000886163-25-000051
10-Q31 Mar 20259 May 202539 days0000886163-25-000036
10-K31 Dec 202428 Feb 202559 days0000886163-25-000012
10-Q30 Sep 20248 Nov 202439 days0000886163-24-000078
10-Q30 Jun 20247 Aug 202438 days0000886163-24-000071
10-Q31 Mar 20248 May 202438 days0000886163-24-000032
10-K31 Dec 202329 Feb 202460 days0000886163-24-000009
10-Q30 Sep 20239 Nov 202340 days0000886163-23-000086
10-Q30 Jun 20239 Aug 202340 days0000886163-23-000050
10-Q31 Mar 20238 May 202338 days0000886163-23-000027
10-K31 Dec 202228 Feb 202359 days0000886163-23-000007
10-Q30 Sep 20228 Nov 202239 days0000886163-22-000135
10-Q30 Jun 20229 Aug 202240 days0000886163-22-000117
10-Q31 Mar 20229 May 202239 days0000886163-22-000049
10-K31 Dec 202128 Feb 202259 days0000886163-22-000030
10-Q30 Sep 20219 Nov 202140 days0000886163-21-000130
10-Q30 Jun 20213 Aug 202134 days0000886163-21-000119
10-Q31 Mar 20216 May 202136 days0000886163-21-000069
10-K31 Dec 202024 Feb 202155 days0000886163-21-000050
10-Q30 Sep 20206 Nov 202037 days0000886163-20-000122
10-Q30 Jun 20207 Aug 202038 days0000886163-20-000097
10-Q31 Mar 20208 May 202038 days0000886163-20-000061
10-K31 Dec 201927 Feb 202058 days0000886163-20-000025
10-Q30 Sep 20198 Nov 201939 days0000886163-19-000199
10-Q30 Jun 20198 Aug 201939 days0000886163-19-000156
10-Q31 Mar 20199 May 201939 days0000886163-19-000077
10-K31 Dec 201828 Feb 201959 days0000886163-19-000041
10-Q30 Sep 20188 Nov 201839 days0000886163-18-000162
10-Q30 Jun 20188 Aug 201839 days0000886163-18-000113
10-Q31 Mar 20189 May 201839 days0000886163-18-000063
10-K31 Dec 20171 Mar 201860 days0000886163-18-000030
10-Q30 Sep 20179 Nov 201740 days0000886163-17-000127
10-Q30 Jun 20179 Aug 201740 days0000886163-17-000091
10-Q31 Mar 20179 May 201739 days0000886163-17-000055
10-K31 Dec 201628 Feb 201759 days0000886163-17-000021
10-Q30 Sep 201614 Nov 201645 days0000886163-16-000245
10-Q30 Jun 20164 Aug 201635 days0000886163-16-000208

Source: SEC EDGAR company submissions for CIK 0000886163. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.